New product intros (abaloparatide, deflazacort (new indication), denosumab (new indication), dimethyl fumarate (new indication), dinalbuphine sebacate, glecaprevir/pibrentasvir (new combination), guselkumab, inotuzumab ozogamicin, neratinib, pembrolizumab (new indication), prasterone, sofosbuvir/velpatasvir/voxilaprevir (new combination).

• Localización: Medicamentos de actualidad = Drugs of today, ISSN 1699-3993, Vol. 53, Nº. 8, 2017, págs. 459-463
• Idioma: inglés
• Texto completo no disponible (Saber más ...)